OXON_EPIDEMIOLOGY_LIMITED - Accounts

OXON EPIDEMIOLOGY LIMITED - Company Information

Print Friendly Version

Company Registration No. 06489173 (England and Wales)

OXON EPIDEMIOLOGY LIMITED

UNAUDITED ABBREVIATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2016

OXON EPIDEMIOLOGY LIMITED

CONTENTS

Page

Abbreviated balance sheet

Notes to the abbreviated accounts

2 - 3

OXON EPIDEMIOLOGY LIMITED

ABBREVIATED BALANCE SHEET

AS AT

31 JANUARY 2016

- 1 -

2016

2015

Notes

Fixed assets

Tangible assets

3,629

2,151

Current assets

Debtors

291,193

215,466

Cash at bank and in hand

222,343

68,667

513,536

284,133

Creditors: amounts falling due within one year

(149,191)

(90,493)

Net current assets

364,345

193,640

Total assets less current liabilities

367,974

195,791

Creditors: amounts falling due after more than one year

(51,520)

316,454

195,791

Capital and reserves

Called up share capital

Profit and loss account

316,452

195,789

Shareholders' funds

316,454

195,791

For the financial year ended 31 January 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

Approved by the Board for issue on 28 October 2016

Dr N Qizilbash

Director

Company Registration No. 06489173

OXON EPIDEMIOLOGY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS

FOR THE YEAR ENDED 31 JANUARY 2016

- 2 -

Accounting policies

1.1

Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).

1.2

Compliance with accounting standards

The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).

1.3

Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.4

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Computer equipment

33.33% straight line method

Fixtures, fittings & equipment

25% straight line method

1.5

Foreign currency translation

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.

Fixed assets

Tangible assets

Cost

At 1 February 2015

28,886

Additions

4,121

At 31 January 2016

33,007

Depreciation

At 1 February 2015

26,736

Charge for the year

2,642

At 31 January 2016

29,378

Net book value

At 31 January 2016

3,629

At 31 January 2015

2,151

OXON EPIDEMIOLOGY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)

FOR THE YEAR ENDED 31 JANUARY 2016

- 3 -

Share capital

2016

2015

Allotted, called up and fully paid

2 Ordinary shares of £1 each